The Best of Our 2021 Interviews

In this episode, we are joined by Elizabeth Cerceo, MD to explore the critical role of resilience and sustainability in the healthcare industry. The discussion highlights how healthcare systems can adapt to crises like extreme weather events and pandemics while maintaining qualit ...  عرض المزيد

While major advances in screening, targeted treatment and immunotherapy have transformed outcomes for non-small cell lung cancer, progress against small cell lung cancer (SCLC) has lagged behind. In this episode, Jacob Sands, MD, of Dana-Farber Cancer Institute and Harvard Medica ...  عرض المزيد

Dr. Lauren Kim discusses the use of normalized join-count in predicting emphysema progression with Dr. Sukhraj Virdee and Dr. Miranda Kirby.  CT Chest Imaging Using Normalized Join-Count:Predicting Emphysema Progression in the CanCOLD Study. Virdee et al. Radiology 2024; 312(1):e ...  عرض المزيد

Story at-a-glance Chronic respiratory diseases remain profitable but poorly treated, subjecting patients to expensive healthcare, impaired stamina, and painful decline DMSO is an "umbrella remedy" treating diverse ailments through therapeutic properties including reducing inflamm ...  عرض المزيد

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ...  عرض المزيد

Kieran Walsh, clinical director at BMJ, asks Matt Castleden, GP and editor for BMJ Best Practice and BMJ Learning, to summarise the latest clinical guidance in acute medicine. Dr Castleden updates us on recent recommendations on pulmonary embolism, and also acute respiratory dist ...  عرض المزيد